BDBM628625 4-[(1R)-2-[(5-Chloropyridin-2-yl)methyl]-1-({1-[hydroxy(2H2)methyl]cyclopropyl}(2H2)methoxy)-5-(2- hydroxypropan-2-yl)-3-oxo-2,3-dihydro-1H-isoindol-1-yl]benzonitrile::US20230338337, Compound 48

SMILES CC1CC1(O)[C@@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(C)O)c1ccc(cc1)C#N

InChI Key InChIKey=XAQGOIBSVALOMK-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 628625   

TargetE3 ubiquitin-protein ligase Mdm2(Human)
Otsuka Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 628625BDBM628625(4-[(1R)-2-[(5-Chloropyridin-2-yl)methyl]-1-({1-[hy...)
Affinity DataIC50: 18nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
US Patent